MiNK Therapeutics Q2 EPS USD -0.62
INKT•Q2 results
MiNK Therapeutics Q2 net income was USD -3.1 million.
Related News
Standard Lithium says South West Arkansas pilot lithium carbonate powers Nano One LFP battery cell tests
SLI•
Amundi Physical Metals issues 70,000 Amundi Physical Gold ETC securities in new tranche offering
GLD•
Valvoline launches USD 500 million senior notes offering due 2034
VVV•
Allstate CFO Christian M. Lown files initial beneficial ownership statement
ALL•
Jones Soda Q2 revenue doubles; outlook raised, expects strong Q3
JSDA•